Royal Bank of Canada’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25M Sell
299,007
-39,458
-12% -$3.24M ﹤0.01% 1304
2025
Q4
$31M Sell
338,465
-12,637
-4% -$1.21M 0.01% 1189
2025
Q3
$33.3M Sell
351,102
-123,485
-26% -$11.6M 0.01% 1249
2025
Q2
$49.7M Buy
474,587
+68,353
+17% +$6.48M 0.01% 933
2025
Q1
$35.9M Sell
406,234
-26,956
-6% -$2.76M 0.01% 959
2024
Q4
$41.6M Buy
433,190
+41,434
+11% +$3.86M 0.01% 919
2024
Q3
$32.1M Buy
391,756
+70,791
+22% +$5.46M 0.01% 1056
2024
Q2
$27.7M Sell
320,965
-9,728
-3% -$786K 0.01% 1074
2024
Q1
$27M Sell
330,693
-21,768
-6% -$1.7M 0.01% 1092
2023
Q4
$23.4M Buy
352,461
+7,209
+2% +$500K 0.01% 1198
2023
Q3
$25.2M Buy
345,252
+1,977
+0.6% +$134K 0.01% 1031
2023
Q2
$21.7M Sell
343,275
-5,149
-1% -$299K 0.01% 1123
2023
Q1
$20.5M Sell
348,424
-82,987
-19% -$5.04M 0.01% 1122
2022
Q4
$26.6M Sell
431,411
-63,544
-13% -$4.27M 0.01% 986
2022
Q3
$33.2M Buy
494,955
+31,860
+7% +$2.02M 0.01% 803
2022
Q2
$28.4M Buy
463,095
+181
+0% +$11.6K 0.01% 907
2022
Q1
$31.2M Sell
462,914
-180,720
-28% -$9.76M 0.01% 975
2021
Q4
$28.5M Sell
643,634
-54,845
-8% -$3.19M 0.01% 1153
2021
Q3
$45.2M Buy
698,479
+10,610
+2% +$737K 0.01% 806
2021
Q2
$55.4M Sell
687,869
-3,902
-0.6% -$297K 0.01% 699
2021
Q1
$47M Sell
691,771
-70,836
-9% -$5.57M 0.01% 736
2020
Q4
$53.2M Sell
762,607
-113,033
-13% -$7.03M 0.02% 685
2020
Q3
$45M Buy
875,640
+53,762
+7% +$2.95M 0.02% 655
2020
Q2
$48.2M Buy
821,878
+54,821
+7% +$3.03M 0.02% 589
2020
Q1
$38.8M Buy
767,057
+102,567
+15% +$6.81M 0.02% 591
2019
Q4
$49.2M Buy
664,490
+42,404
+7% +$2.65M 0.02% 636
2019
Q3
$35.5M Buy
622,086
+13,284
+2% +$882K 0.01% 735
2019
Q2
$39.8M Buy
608,802
+28,074
+5% +$1.95M 0.02% 687
2019
Q1
$43M Sell
580,728
-56,483
-9% -$3.97M 0.02% 635
2018
Q4
$38M Buy
637,211
+473
+0.1% +$38.1K 0.02% 641
2018
Q3
$60.1M Sell
636,738
-87,059
-12% -$7.5M 0.03% 510
2018
Q2
$54.4M Sell
723,797
-200,557
-22% -$14.4M 0.02% 527
2018
Q1
$56M Sell
924,354
-467,868
-34% -$25.3M 0.03% 534
2017
Q4
$65M Buy
1,392,222
+350,138
+34% +$17.3M 0.03% 485
2017
Q3
$52.7M Buy
1,042,084
+778,306
+295% +$36.2M 0.03% 536
2017
Q2
$13.1M Buy
263,778
+79,144
+43% +$3.7M 0.01% 1332
2017
Q1
$7.84M Buy
184,634
+181,117
+5,150% +$8.01M ﹤0.01% 1626
2016
Q4
$142K Buy
3,517
+1,871
+114% +$72.3K ﹤0.01% 4690
2016
Q3
$63K Buy
+1,646
New +$52.1K ﹤0.01% 5046
2016
Q1
Sell
-219
Closed -$5K 6481
2015
Q4
$5K Sell
219
-1,236
-85% -$38K ﹤0.01% 6154
2015
Q3
$43K Buy
1,455
+12
+0.8% +$377 ﹤0.01% 5214
2015
Q2
$46K Buy
1,443
+1,171
+431% +$31.4K ﹤0.01% 5259
2015
Q1
$7K Sell
272
-187
-41% -$4.05K ﹤0.01% 5660
2014
Q4
$11K Buy
+459
New +$9.96K ﹤0.01% 5578

Other funds holding HQY

Royal Bank of Canada's HQY Position: Q1 2026 in Review

Royal Bank of Canada reduced its HealthEquity (HQY) stake by 12% in Q1 2026, selling an estimated $3.24M and leaving 299,007 shares worth $25M. The position accounts for ﹤0.01% of the portfolio, ranked #1304.

Royal Bank of Canada first reported a position in HQY in Q4 2014 and has held it in 44 quarters since. The position peaked at $65M in Q4 2017. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.

  • Royal Bank of Canada held 299,007 shares of HealthEquity worth $25M as of Q1 2026.
  • Royal Bank of Canada sold 39,458 HealthEquity shares in Q1 2026, an estimated $3.24M.
  • HealthEquity made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1304 holding.
  • Royal Bank of Canada first reported a position in HealthEquity in Q4 2014 and has held it in 44 quarters since.
  • Royal Bank of Canada's HealthEquity position peaked at $65M in Q4 2017.
  • 485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.